Compare VTOL & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTOL | INVA |
|---|---|---|
| Founded | 1948 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.7B |
| IPO Year | 2011 | 2000 |
| Metric | VTOL | INVA |
|---|---|---|
| Price | $42.80 | $21.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $58.00 | $32.80 |
| AVG Volume (30 Days) | 227.3K | ★ 781.2K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | 34.58 | ★ 816.67 |
| EPS | 1.14 | ★ 1.25 |
| Revenue | ★ $1,490,512,000.00 | $217,217,000.00 |
| Revenue This Year | $11.64 | $8.95 |
| Revenue Next Year | $5.59 | $12.65 |
| P/E Ratio | $37.39 | ★ $16.61 |
| Revenue Growth | 5.30 | ★ 62.63 |
| 52 Week Low | $35.03 | $16.52 |
| 52 Week High | $50.38 | $25.15 |
| Indicator | VTOL | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 49.22 |
| Support Level | $42.05 | $20.44 |
| Resistance Level | $44.42 | $21.73 |
| Average True Range (ATR) | 1.09 | 0.48 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 58.55 | 59.07 |
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.